Published in J Med Internet Res on December 14, 2015
Beyond clinical utility: The multiple values of DTC genetics. Appl Transl Genom (2016) 0.80
Transparency of genetic testing services for 'health, wellness and lifestyle': analysis of online prepurchase information for UK consumers. Eur J Hum Genet (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth (2009) 8.28
Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med (2011) 6.90
Best practices for survey research reports: a synopsis for authors and reviewers. Am J Pharm Educ (2008) 5.79
An agenda for personalized medicine. Nature (2009) 4.14
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol (2007) 3.19
Concordance study of 3 direct-to-consumer genetic-testing services. Clin Chem (2010) 2.33
Evaluation of risk prediction updates from commercial genome-wide scans. Genet Med (2009) 2.30
Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates. J Genet Couns (2012) 2.25
Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genet Med (2010) 2.23
Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med (2009) 2.07
Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96
Personal genomics and individual identities: motivations and moral imperatives of early users. New Genet Soc (2010) 1.96
Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. J Genet Couns (2012) 1.93
Impact of direct-to-consumer genomic testing at long term follow-up. J Med Genet (2013) 1.86
Direct-to-consumer sales of genetic services on the Internet. Genet Med (2003) 1.78
Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genet Med (2010) 1.78
Patients' understanding of and responses to multiplex genetic susceptibility test results. Genet Med (2012) 1.75
The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics (2011) 1.69
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation. J Med Genet (2013) 1.61
Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J Gen Intern Med (2011) 1.56
Personal genome testing in medical education: student experiences with genotyping in the classroom. Genome Med (2013) 1.44
Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. J Genet Couns (2011) 1.42
A survey of UK public interest in internet-based personal genome testing. PLoS One (2010) 1.39
Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. Eur J Hum Genet (2012) 1.38
Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet (2012) 1.36
Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing. J Med Internet Res (2010) 1.35
Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics (2011) 1.30
Quality of online pharmacies and websites selling prescription drugs: a systematic review. J Med Internet Res (2011) 1.30
Association between health-service use and multiplex genetic testing. Genet Med (2012) 1.29
Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. J Community Genet (2010) 1.28
Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. J Community Genet (2011) 1.28
Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing. PeerJ (2013) 1.26
Public interest in predictive genetic testing, including direct-to-consumer testing, for susceptibility to major depression: preliminary findings. Eur J Hum Genet (2010) 1.26
Is there a doctor in the house? : The presence of physicians in the direct-to-consumer genetic testing context. J Community Genet (2011) 1.25
The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genet Med (2008) 1.23
CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Genet Med (2010) 1.21
Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genet Test (2008) 1.21
Variations in predicted risks in personal genome testing for common complex diseases. Genet Med (2013) 1.20
Parents' attitudes toward pediatric genetic testing for common disease risk. Pediatrics (2011) 1.18
Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet Med (2007) 1.18
Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors. Fam Cancer (2009) 1.18
Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med (2012) 1.17
An exploration of genetic health professionals' experience with direct-to-consumer genetic testing in their clinical practice. Eur J Hum Genet (2012) 1.17
Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs. Genet Med (2011) 1.16
Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies. Curr Genet Med Rep (2013) 1.16
Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health (2008) 1.15
Medical and graduate students' attitudes toward personal genomics. Genet Med (2011) 1.14
An epidemiological perspective on the future of direct-to-consumer personal genome testing. Investig Genet (2010) 1.13
Self diagnosis of Lynch syndrome using direct to consumer genetic testing: a case study. J Genet Couns (2011) 1.13
Health-care referrals from direct-to-consumer genetic testing. Genet Test Mol Biomarkers (2010) 1.13
Willingness to pay for genetic testing: a study of attitudes in a Canadian population. Public Health Genomics (2009) 1.10
Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc (2011) 1.09
Associations between anticipated reactions to genetic test results and interest in genetic testing: will self-selection reduce the potential for harm? Genet Test (2008) 1.08
Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics (2008) 1.08
A randomized trial of genetic information for personalized nutrition. Genes Nutr (2012) 1.08
Experiences of early users of direct-to-consumer genomics in Switzerland: an exploratory study. Public Health Genomics (2012) 1.03
Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training. J Genet Couns (2013) 1.03
Multigenic condition risk assessment in direct-to-consumer genomic services. Genet Med (2010) 1.02
The on-line promotion and sale of nutrigenomic services. Genet Med (2008) 1.01
"It's not like judgment day": public understanding of and reactions to personalized genomic risk information. J Genet Couns (2011) 1.01
Counseling customers: emerging roles for genetic counselors in the direct-to-consumer genetic testing market. J Genet Couns (2012) 1.00
Educational needs of primary care physicians regarding direct-to-consumer genetic testing. J Genet Couns (2011) 1.00
A family experience of personal genomics. J Genet Couns (2012) 1.00
State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation. Proc Nutr Soc (2013) 0.99
Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms? Eur J Hum Genet (2011) 0.98
Physicians' opinion for 'new' genetic testing in Japan. J Hum Genet (2009) 0.98
Increasing Public Awareness of Direct-to-Consumer Genetic Tests: Health Care Access, Internet Use, and Population Density Correlates. J Cancer Epidemiol (2012) 0.98
Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations. J Genet Couns (2011) 0.94
Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization. J Genet Couns (2012) 0.94
Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample. Psychol Med (2010) 0.93
Academic family physicians' perception of genetic testing and integration into practice: a CERA study. Fam Med (2013) 0.93
Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”. J Genet Couns (2012) 0.93
Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testing. Genome Med (2013) 0.92
Perceptions of genetic counseling services in direct-to-consumer personal genomic testing. Clin Genet (2013) 0.92
Playing a part in research? University students' attitudes to direct-to-consumer genomics. Public Health Genomics (2014) 0.92
Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study. Eur J Public Health (2013) 0.91
Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing. Clin Genet (2014) 0.91
Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature. J Community Genet (2013) 0.90
Awareness of direct-to-consumer genetic tests and use of genetic tests among Puerto Rican adults, 2009. Prev Chronic Dis (2011) 0.90
The challenge of implementing genetic tests with clinical utility while avoiding unsound applications. J Community Genet (2012) 0.89
Effect of direct-to-consumer genetic tests on health behaviour and anxiety: a survey of consumers and potential consumers. J Genet Couns (2013) 0.89
Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians. Per Med (2012) 0.89
Predictors of interest in direct-to-consumer genetic testing. Psychol Health (2011) 0.89
Myths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics. Public Health Genomics (2010) 0.88
Experience, knowledge, and opinions about childhood genetic testing in Batten disease. Mol Genet Metab (2013) 0.87
Psychological distress with direct-to-consumer genetic testing: a case report of an unexpected BRCA positive test result. J Genet Couns (2012) 0.87
Systematic evaluation of personal genome services for Japanese individuals. J Hum Genet (2013) 0.86
Media coverage of direct-to-consumer genetic testing. J Genet Couns (2011) 0.86
Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk. Transl Behav Med (2012) 0.86
Misinterpretation of TPMT by a DTC genetic testing company. Clin Pharmacol Ther (2014) 0.85
Characteristics of genomic test consumers who spontaneously share results with their health care provider. Health Commun (2013) 0.85
Attitudes toward direct-to-consumer advertisements and online genetic testing among high-risk women participating in a hereditary cancer clinic. J Health Commun (2011) 0.85
Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two Cases. New Genet Soc (2011) 0.85
The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations. Clin Genet (2011) 0.83
Gatekeepers or intermediaries? The role of clinicians in commercial genomic testing. PLoS One (2014) 0.83
Awareness and uptake of direct-to-consumer genetic testing among cancer cases, their relatives, and controls: the Northwest Cancer Genetics Network. Genet Test Mol Biomarkers (2012) 0.83
Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive? Hered Cancer Clin Pract (2011) 0.82
The effects of learning about one's own genetic susceptibility to alcoholism: a randomized experiment. Genet Med (2012) 0.82
Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis (2004) 1.44
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS (2004) 1.44
GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer (2004) 1.41
Quality of online pharmacies and websites selling prescription drugs: a systematic review. J Med Internet Res (2011) 1.30
Use of cognitive enhancement medication among northern Italian university students. J Addict Med (2012) 1.03
"Save 30% if you buy today". Online pharmacies and the enhancement of peripheral thinking in consumers. Pharmacoepidemiol Drug Saf (2010) 1.02
Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol (2008) 0.99
Cyberdrugs: a cross-sectional study of online pharmacies characteristics. Eur J Public Health (2009) 0.99
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther (2010) 0.95
Narrative in cancer research and policy: voice, knowledge and context. Crit Rev Oncol Hematol (2012) 0.94
The world of e-patients: A content analysis of online social networks focusing on diseases. Telemed J E Health (2010) 0.90
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail (2005) 0.89
Italian hospitals on the web: a cross-sectional analysis of official websites. BMC Med Inform Decis Mak (2010) 0.89
Mental disorders associated with benzodiazepine use among older primary care attenders--a regional survey. Soc Psychiatry Psychiatr Epidemiol (2005) 0.87
Assessing the impact of health conditions using the ICF. Disabil Rehabil (2010) 0.85
Biodegradability, toxicity and mutagenicity of detergents: Integrated experimental evaluations. Ecotoxicol Environ Saf (2012) 0.85
Marketing and pricing strategies of online pharmacies. Health Policy (2009) 0.85
Online consultations in cyberpharmacies: completeness and patient safety. Telemed J E Health (2009) 0.84
Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy). Cancer Causes Control (2005) 0.83
Soil contamination detected using bacterial and plant mutagenicity tests and chemical analyses. Environ Res (2002) 0.81
How has the flu virus infected the Web? 2010 influenza and vaccine information available on the Internet. BMC Public Health (2013) 0.80
A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project. BMC Public Health (2011) 0.80
Polychlorinated biphenyls and non-Hodgkin's lymphoma: a case-control study in Northern Italy. Environ Res (2011) 0.79
Polychlorinated biphenyls and thyroid hormone serum concentrations among people living in a highly polluted area: a cross-sectional population-based study. Environ Res (2008) 0.79
Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study. Eur Heart J (2004) 0.79
Meeting the ranging of informational needs of chronic low back pain sufferers: conceptual design and rationale of the interactive website ONESELF. Disabil Rehabil (2009) 0.78
Online patient education and risk assessment: project OPERA from Cancerbackup. Putting inherited breast cancer risk information into context using argumentation theory. Patient Educ Couns (2007) 0.78
[A survey to assess consumption, attitudes and knowledge regarding tobacco smoke amongst secondary school students in Brescia (Italy)]. Ig Sanita Pubbl (2010) 0.77
Polychlorinated biphenyls in serum, liver and adipose tissue of subjects with hepatocellular carcinoma living in a highly polluted area. Chemosphere (2013) 0.77
[A study to detect the presence of genotoxins in the drinking water distribution systems of four Italian cities]. Ig Sanita Pubbl (2008) 0.77
Nutritional supplements for diabetes sold on the internet: business or health promotion? BMC Public Health (2013) 0.77
Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage. Occup Environ Med (2013) 0.76
Not a good buy: value for money of prescription drugs sold on the internet. Health Policy (2012) 0.76
A web search on environmental topics: what is the role of ranking? Telemed J E Health (2013) 0.75
Being a person with disabilities or experiencing disability: Two perspectives on the social response to disability. J Rehabil Med (2017) 0.75
Health communication meets artificial intelligence. Patient Educ Couns (2013) 0.75
[When health "sells": presence and characteristics of health-related advertising in the Italian press]. Ig Sanita Pubbl (2012) 0.75
Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach. Int Arch Occup Environ Health (2014) 0.75
[Use of information systems for managing healthcare services in a long-term care facility]. Ig Sanita Pubbl (2009) 0.75
[Evaluation of the mutagenicity of detergents by tests on bacteria, plant cells and human leucocytes.]. Ig Sanita Pubbl (2010) 0.75
Why a new journal in Public Health? J Public Health Res (2012) 0.75